Search Results - "Colhoun HM"

Semaglutide-associated risk of nonarteritic anterior ischemic optic neuropathy in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies.

Authors: Chrzanowski, Jędrzej Walicka, Magdalena Burzyński, Jacek et al.

Source: PLoS Medicine. 5/21/2026, Vol. 23 Issue 5, p1-18. 18p.

Mapping Global Research on Adverse Effects of GLP-1 Receptor Agonists (2006-2025): A Scopus-Based Bibliometric and Thematic Analysis.

Authors: Abdelrahman, Riad Mohammed Musa, Taha Hussein Arbab, Ismail Adam et al.

Source: Inquiry (00469580). 4/25/2026, Vol. 63, p1-19. 19p.

Subject Terms: *Interprofessional relations, *Bibliographic databases, *Data analysis, *Citation analysis, *Bibliometrics, Glucagon-like peptide-1 agonists, Pharmacology, Pearson correlation (Statistics), Patient safety, Professional practice, Descriptive statistics, World health, Thematic analysis, Medical research, Statistics, Evidence-based medicine, Data analysis software

Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply.

Authors: Colhoun HM McGurnaghan SJ McKeigue PM

Source: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2021 Apr; Vol. 9 (4), pp. 201.

Publication Type: Letter; Comment

Journal Info: Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE

Semaglutide-associated Twiddler syndrome.

Authors: Seiler, Thomas Noti, Fabian Laimer, Markus et al.

Source: JCEM Case Reports. Jun2026, Vol. 4 Issue 6, p1-3. 3p.

Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study.

Authors: Chan, Linda Xu, Wanchun Chan, Esther W. Y. et al.

Source: PLoS Medicine. 6/24/2026, Vol. 23 Issue 6, p1-20. 20p.

Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].

Authors: Phillip M Achenbach P Addala A et al.

Source: Diabetologia [Diabetologia] 2025 Apr; Vol. 68 (4), pp. 892-895. Date of Electronic Publication: 2025 Feb 12.

Publication Type: Letter

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE; In Process

DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes.

Authors: Roshandel, Delnaz Chen, Zhuo Canty, Angelo J. et al.

Source: Clinical Epigenetics. 4/5/2020, Vol. 12 Issue 1, p1-16. 16p.

Bayesian network imputation methods applied to multi-omics data identify putative causal relationships in a type 2 diabetes dataset containing incomplete data: An IMI DIRECT Study.

Authors: Howey, Richard Adam, Jonathan Adamski, Jerzy et al.

Source: PLoS Genetics. 7/15/2025, Vol. 21 Issue 7, p1-20. 20p.

Mediating factors in the relationship between combat-related traumatic injury and myocardial blood flow reserve: The ADVANCE cohort study.

Authors: Boos, Christopher J Schofield, Susie Maqsood, Rabeea et al.

Source: PLoS ONE. 3/19/2026, Vol. 21 Issue 3, p1-13. 13p.

Evaluating the Effects of Glucagon-Like Peptide 1 Receptor Agonists as a Secondary Prevention in Peripheral Arterial Disease: A Meta-Analysis.

Authors: Elliott, Beth Tomlinson, Ellie Desai, Nirali et al.

Source: Diabetes Therapy. Mar2026, Vol. 17 Issue 3, p449-459. 11p.

Correlates of Healthcare Patients' Interest in and Use of Medication and Non-Evidence-Based Approaches to Weight Loss.

Authors: Wilkins, Francesca L. Moore, Wendy S. Jackson, Jalen R. et al.

Source: American Journal of Health Promotion. Jun2026, Vol. 40 Issue 5, p576-590.

Impact of semaglutide withdrawal on cardiometabolic profile and physiology of energy balance: Recovery effects after semaglutide termination – The REST trial study protocol.

Authors: Yevusiak, Taras Weisman, Alanna Retnakaran, Ravi et al.

Source: PLoS ONE. 7/27/2026, Vol. 21 Issue 7, p1-8. 8p.

Association of urinary post-translationally modified fetuin-A fragments with diabetic kidney disease risk stratification in Japanese patients with type 2 diabetes.

Authors: Mori, Toshiko Ito, Hiroyuki Kozasa, Taiki et al.

Source: PLoS ONE. 7/2/2026, Vol. 21 Issue 7, p1-19. 19p.

Severity of COVID-19 Omicron Variants: A Global Systematic Review.

Authors: Malhotra, Deepa Nepal, Rajeev M. Zografaki, Irini et al.

Source: Infectious Diseases & Therapy. Jul2026, Vol. 15 Issue 7, p1827-1849. 23p.

Tirzepatide and the Cardiovascular Continuum: Metabolic, Cardiorenal and Heart Failure Evidence.

Authors: Parlati, Antonio LM Martini, Luca Nardi, Ermanno et al.

Source: Clinical Medicine Insights: Cardiology. 6/16/2026, Vol. 20, p1-10. 10p.

Contemporary Type 2 Diabetes Guidelines: Converging Evidence, Diverging Strategies, and the Position of the Korean Diabetes Association Framework.

Authors: Kim, Suk Kyeong Kim, Dong-Lim Song, Keeho et al.

Source: Endocrinology & Metabolism. Jun2026, Vol. 41 Issue 3, p351-357. 7p.

Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category.

Authors: Navas, Angelo Noone, Joshua Laney, Nathan et al.

Source: Diabetes Therapy. Jun2026, Vol. 17 Issue 6, p897-910. 14p.

Real-World Effectiveness and Safety of Escalating Once-Weekly Semaglutide from 0.5 to 1.0 mg in Type 2 Diabetes.

Authors: Sato, Genki Uchino, Hiroshi Takuma, Kota et al.

Source: Diabetes Therapy. May2026, Vol. 17 Issue 5, p753-770. 18p.

From Metabolic Syndrome to Cardiovascular– Kidney–Metabolic Syndrome and Systemic Metabolic Disorder: A Call to Recognize the Progressive Multisystemic Dysfunction.

Authors: Özyüncü, Nil Erol, Çetin

Source: Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi. Aug2025, Vol. 29 Issue 8, p384-393. 10p.

Comment on 'Glycemic control and renal function decline in patients with chronic coronary syndrome: A multicenter cohort study'.

Authors: Li, Jiandi¹ (AUTHOR) lijiandi2026@163.com

Source: Journal of Diabetes Investigation. Jul2026, Vol. 17 Issue 7, p1237-1238. 2p.